Enanta Pharmaceuticals, Inc. (ENTA)
NASDAQ: ENTA · Real-Time Price · USD
13.14
+0.17 (1.31%)
Apr 2, 2026, 4:00 PM EDT - Market closed
Enanta Pharmaceuticals Market Cap
Enanta Pharmaceuticals has a market cap or net worth of $381.31 million as of April 2, 2026. Its market cap has increased by 177.52% in one year.
Market Cap
381.31M
Enterprise Value
332.59M
1-Year Change
177.52%
Ranking
Category
Stock Price
$13.14
Market Cap Chart
Since March 21, 2013, Enanta Pharmaceuticals's market cap has increased from $289.30M to $381.31M, an increase of 31.81%. That is a compound annual growth rate of 2.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 381.30M | -16.23% |
| Dec 31, 2025 | 455.20M | 273.42% |
| Dec 31, 2024 | 121.90M | -38.50% |
| Dec 29, 2023 | 198.20M | -79.51% |
| Dec 30, 2022 | 967.50M | -36.34% |
| Dec 31, 2021 | 1.52B | 79.81% |
| Dec 31, 2020 | 845.30M | -30.63% |
| Dec 31, 2019 | 1.22B | -11.43% |
| Dec 31, 2018 | 1.38B | 22.59% |
| Dec 29, 2017 | 1.12B | 75.96% |
| Dec 30, 2016 | 637.80M | 2.77% |
| Dec 31, 2015 | 620.60M | -34.40% |
| Dec 31, 2014 | 946.00M | 93.06% |
| Dec 31, 2013 | 490.00M | 69.37% |
| Mar 21, 2013 | 289.30M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sutro Biopharma | 393.97M |
| XOMA Royalty | 392.98M |
| Lineage Cell Therapeutics | 391.07M |
| X4 Pharmaceuticals | 385.50M |
| Rocket Pharmaceuticals | 385.42M |
| Century Therapeutics | 382.81M |
| Autolus Therapeutics | 375.26M |
| Benitec Biopharma | 374.06M |